IPCA LABORATORIES LTD. - Updates on Open Offer to the Shareholder of Krebs Biochemicals & Industries

Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a Copy of Final Letter of Offer in respect of the proposed Open Offer to the shareholders of Krebs Biochemicals & Industries Ltd ("Target Company") under Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 [SEBI SAST Regulations] by Ipca Laboratories Limited ("Acquirer").